Direct-to-Consumer Genetic Testing Market Report, 2025-2034

Direct-to-Consumer Genetic Testing Market - By Test Type, By Technology, By Distribution Channel - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Test type trends

2.2.3&nbsp;&nbsp;&nbsp; Technology trends

2.2.4&nbsp;&nbsp;&nbsp; Distribution channel trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.1.1&nbsp;&nbsp;&nbsp; Supplier landscape

3.1.2&nbsp;&nbsp;&nbsp; Value addition at each stage

3.1.3&nbsp;&nbsp;&nbsp; Factors affecting the value chain

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising demand for personalized solutions based on genetic insights

3.2.1.2&nbsp;&nbsp;&nbsp; Growing technology advancement in genomic sequencing

3.2.1.3&nbsp;&nbsp;&nbsp; Increased awareness of genetic disorders

3.2.1.4&nbsp;&nbsp;&nbsp; Expanding accessibility of DTC through online channels

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Privacy and data security

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory challenges

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Expansion of online distribution channels

3.2.3.2&nbsp;&nbsp;&nbsp; Strategic alliances and partnerships

3.2.3.3&nbsp;&nbsp;&nbsp; Increasing penetration in emerging markets

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; U.S.

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.2.1&nbsp;&nbsp;&nbsp; Germany

3.4.2.2&nbsp;&nbsp;&nbsp; UK

3.4.2.3&nbsp;&nbsp;&nbsp; France

3.4.2.4&nbsp;&nbsp;&nbsp; Spain

3.4.2.5&nbsp;&nbsp;&nbsp; Italy

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.4.3.1&nbsp;&nbsp;&nbsp; China

3.4.3.2&nbsp;&nbsp;&nbsp; Japan

3.4.3.3&nbsp;&nbsp;&nbsp; India

3.4.3.4&nbsp;&nbsp;&nbsp; Australia

3.4.4&nbsp;&nbsp;&nbsp; Latin America

3.4.5&nbsp;&nbsp;&nbsp; MEA

3.5&nbsp;&nbsp;&nbsp; Investment and funding landscape in the genetic testing industry

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.6.1&nbsp;&nbsp;&nbsp; Emerging technologies

3.6.2&nbsp;&nbsp;&nbsp; Current technologies

3.7&nbsp;&nbsp;&nbsp; Data privacy concerns

3.8&nbsp;&nbsp;&nbsp; Value chain analysis

3.9&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.10&nbsp;&nbsp;&nbsp; Pricing analysis

3.11&nbsp;&nbsp;&nbsp; Future market trends

3.12&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.13&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Merger and acquisition

4.6.2&nbsp;&nbsp;&nbsp; Partnership and collaboration

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Carrier screening

5.3&nbsp;&nbsp;&nbsp; Predictive testing

5.4&nbsp;&nbsp;&nbsp; Ancestry testing

5.5&nbsp;&nbsp;&nbsp; Nutrigenomic testing

5.6&nbsp;&nbsp;&nbsp; Pharmacogenomic testing

5.7&nbsp;&nbsp;&nbsp; Skincare testing

5.8&nbsp;&nbsp;&nbsp; Other test types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Microarray-based testing

6.3&nbsp;&nbsp;&nbsp; Single-nucleotide polymorphism (SNP) chips

6.4&nbsp;&nbsp;&nbsp; Whole genome sequencing (WGS)

6.5&nbsp;&nbsp;&nbsp; Other technologies

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Online channels

7.3&nbsp;&nbsp;&nbsp; Over-the-counter (OTC)

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Ancestry

9.2&nbsp;&nbsp;&nbsp; Blueprint Genetics

9.3&nbsp;&nbsp;&nbsp; Counsyl

9.4&nbsp;&nbsp;&nbsp; Dante Lab

9.5&nbsp;&nbsp;&nbsp; DNA Complete

9.6&nbsp;&nbsp;&nbsp; DNA Genotek

9.7&nbsp;&nbsp;&nbsp; Easy DNA

9.8&nbsp;&nbsp;&nbsp; Family Tree DNA (Gene By Gene)

9.9&nbsp;&nbsp;&nbsp; Fulgent Genetics

9.10&nbsp;&nbsp;&nbsp; Genesis Healthcare

9.11&nbsp;&nbsp;&nbsp; Genova Diagnostics (GDX)

9.12&nbsp;&nbsp;&nbsp; Helix

9.13&nbsp;&nbsp;&nbsp; HomeDNA

9.14&nbsp;&nbsp;&nbsp; Identigene

9.15&nbsp;&nbsp;&nbsp; Living DNA

9.16&nbsp;&nbsp;&nbsp; Mapmygenome

9.17&nbsp;&nbsp;&nbsp; MedGenome

9.18&nbsp;&nbsp;&nbsp; MyHeritage

9.19&nbsp;&nbsp;&nbsp; Myriad Genetics, Inc.

9.20&nbsp;&nbsp;&nbsp; Nutrigenomix

9.21&nbsp;&nbsp;&nbsp; Pathway genomics

9.22&nbsp;&nbsp;&nbsp; Quest Diagnostics

9.23&nbsp;&nbsp;&nbsp; Tempus AI

9.24&nbsp;&nbsp;&nbsp; The SkinDNA Company

9.25&nbsp;&nbsp;&nbsp; Veritas Intercontinental 
&nbsp;

DirecttoConsumer Genetic Testing Market

Get a free sample of this report